We obtained a genetic diagnosis in 13.3% of adult patients previously classified as CVID (10/75), where heterozygous variants in TNFRSF13B (TACI) were excluded (except for one pathogenic variant), due to the fact that such variants are likely disease modifying rather than disease causing. Here, TNFRSF13B is linked to common variable immunodeficiency.